Intracellular signal pathways utilized by the hypocretin/orexin receptors

Hypocretins: Integrators of Physiological Functions

Volumn , Issue , 2005, Pages 221-231

  Kukkonen, Jyrki P ^a   Åkerman, Karl E O ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646415110     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-25446-3_14     Document Type: Chapter

References (57)

1. J. Näsman, J. P. Kukkonen, T. Holmqvist and K. E. Åkerman, Different roles for Gi and Go proteins in modulation of adenylyl cyclase type-2 activity, J Neurochem. 83, 1252-61 (2002).
2. A. E. Brady and L. E. Limbird, G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction, Cell Signal. 14, 297-309 (2002).
3. C. Heuss and U. Gerber, G-protein-independent signaling by G-protein-coupled receptors, Trends Neurosci. 23, 469-75 (2000).
4. E. Karteris, H. S. Randeva, D. K. Grammatopoulos, R. B. Jaffe and E. W. Hillhouse, Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals, J Clin Endocrinol Metab. 86, 4512-9 (2001).
5. H. S. Randeva, E. Karteris, D. Grammatopoulos and E. W. Hillhouse, Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis, J Clin Endocrinol Metab. 86, 4808-13 (2001).
6. R. Bernard, R. Lydic and H. A. Baghdoyan, Hypocretin-1 activates G proteins in arousal-related brainstem nuclei of rat, Neuroreport. 13, 447-50 (2002).
7. R. Bernard, R. Lydic and H. A. Baghdoyan, Hypocretin-1 causes G protein activation and increases ACh release in rat pons, Eur J Neurosci. 18, 1775-85 (2003).
8. L. De Lecea, T. S. Kilduff, C. Peyron, X. Gao, P. E. Foye, P. E. Danielson, C. Fukuhara, E. L. Battenberg, V. T. Gautvik, F. S. Bartlett, 2nd, W. N. Frankel, A. N. Van Den Pol, F. E. Bloom, K. M. Gautvik and J. G. Sutcliffe, The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity, Proc Natl Acad Sci U S A. 95, 322-7 (1998).
9. B. M. Ances, J. H. Greenberg and J. A. Detre, Effects of variations in interstimulus interval on activationflow coupling response and somatosensory evoked potentials with forepaw stimulation in the rat, J Cereb Blood Flow Metab. 20, 290-7 (2000).
10. Q. V. Hoang, D. Bajic, M. Yanagisawa, S. Nakajima and Y. Nakajima, Effects of orexin (hypocretin) on GIRK channels, J Neurophysiol. 90, 693-702 (2003).
11. B. Yang and A. V. Ferguson, Orexin-A depolarizes nucleus tractus solitarius neurons through effects on nonselective cationic and K+ conductances, J Neurophysiol. 89, 2167-75 (2003).
12. K. Uramura, H. Funahashi, S. Muroya, S. Shioda, M. Takigawa and T. Yada, Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area, Neuroreport. 12, 1885-9. (2001).
13. A. N. Van Den Pol, P. R. Patrylo, P. K. Ghosh and X. B. Gao, Lateral hypothalamus: Early developmental expression and response to hypocretin (orexin), J Comp Neurol. 433, 349-363. (2001).
14. K. A. Kohlmeier, T. Inoue and C. S. Leonard, Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum, J Neurophysiol. 92, 221-35 (2004).
15. T. M. Korotkova, K. S. Eriksson, H. L. Haas and R. E. Brown, Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro, Regul Pept. 104, 83-89 (2002).
16. R. E. Brown, O. Sergeeva, K. S. Eriksson and H. L. Haas, Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat, Neuropharmacology. 40, 457-9. (2001).
17. K. Hirota, T. Kushikata, M. Kudo, T. Kudo, D. G. Lambert and A. Matsuki, Orexin A and B evoke noradrenaline release from rat cerebrocortical slices, Br J Pharmacol. 134, 1461-6 (2001).
18. M. Rauch, T. Riediger, H. A. Schmid and E. Simon, Orexin A activates leptin-responsive neurons in the arcuate nucleus, Pflugers Arch. 440, 699-703. (2000).
19. D. Burdakov, B. Liss and F. M. Ashcroft, Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger, J Neurosci. 23, 4951-7 (2003).
20. J. J. Hwang, V. J. Dzau and C. C. Liew, Genomics and the pathophysiology of heart failure, Curr Cardiol Rep. 3, 198-207 (2001).
21. G. Grabauskas and H. C. Moises, Gastrointestinal-projecting neurones in the dorsal motor nucleus of the vagus exhibit direct and viscerotopically organized sensitivity to orexin, J Physiol. 549, 37-56 (2003).
22. S. Burlet, C. J. Tyler and C. S. Leonard, Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy, J Neurosci. 22, 2862-72 (2002).
23. K. A. Kohlmeier, T. Inoue and C. S. Leonard, Hypocretin/Orexin peptide signalling in the ascending arousal system: Elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum, J Neurophysiol. (2004).
24. R. E. Brown, O. A. Sergeeva, K. S. Eriksson and H. L. Haas, Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline), J Neurosci. 22, 8850-9 (2002).
25. R. J. Liu, A. N. Van Den Pol and G. K. Aghajanian, Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions, J Neurosci. 22, 9453-64 (2002).
26. T. L. Horvath, C. Peyron, S. Diano, A. Ivanov, G. Aston-Jones, T. S. Kilduff and A. N. Van Den Pol, Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system, J Comp Neurol. 415, 145-59 (1999).
27. A. Ivanov and G. Aston-Jones, Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons, Neuroreport. 11, 1755-8. (2000).
28. A. N. Van Den Pol, X. B. Gao, K. Obrietan, T. S. Kilduff and A. B. Belousov, Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin, J Neurosci. 18, 7962-71 (1998).
29. L. I. Kiyashchenko, B. Y. Mileykovskiy, N. Maidment, H. A. Lam, M. F. Wu, J. John, J. Peever and J. M. Siegel, Release of hypocretin (orexin) during waking and sleep states, J Neurosci. 22, 5282-6 (2002).
30. M. Wu, L. Zaborszky, T. Hajszan, A. N. Van Den Pol and M. Alreja, Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons, J Neurosci. 24, 3527-36 (2004).
31. L. L. Hwang, C. T. Chen and N. J. Dun, Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro, J Physiol. 537, 511-20 (2001).
32. D. E. Clapham, TRP channels as cellular sensors, Nature. 426, 517-24 (2003).
33. O. A. Sergeeva, T. M. Korotkova, A. Scherer, R. E. Brown and H. L. Haas, Co-expression of non-selective cation channels of the transient receptor potential canonical family in central aminergic neurones, J Neurochem. 85, 1547-52 (2003).
34. K. S. Eriksson, O. Sergeeva, R. E. Brown and H. L. Haas, Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus, J Neurosci. 21, 9273-9 (2001).
35. B. Linck, Z. Qiu, Z. He, Q. Tong, D. W. Hilgemann and K. D. Philipson, Functional comparison of the three isoforms of the Na+/Ca2+ exchanger (NCX1, NCX2, NCX3), Am J Physiol. 274, C415-23 (1998).
36. T. Iwamoto and S. Kita, Development and application of Na+/Ca2+ exchange inhibitors, Mol Cell Biochem. 259, 157-61 (2004).
37. J. P. Kukkonen, T. Holmqvist, S. Ammoun and K. E. Akerman, Functions of the orexinergic/hypocretinergic system, Am J Physiol Cell Physiol. 283, C1567-91 (2002).
38. M. L. Barreiro, R. Pineda, V. M. Navarro, M. Lopez, J. S. Suominen, L. Pinilla, R. Senaris, J. Toppari, E. Aguilar, C. Dieguez and M. Tena-Sempere, Orexin 1 receptor messenger ribonucleic acid expression and stimulation of testosterone secretion by orexin-A in rat testis, Endocrinology. 145, 2297-306 (2004).
39. E. Karteris, J. Chen and H. S. Randeva, Expression of human prepro-orexin and signaling characteristics of orexin receptors in the male reproductive system, J Clin Endocrinol Metab. 89, 1957-62 (2004).
40. L. K. Malendowicz, C. Tortorella and G. G. Nussdorfer, Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade, J Steroid Biochem Mol Biol. 70, 185-8 (1999).
41. G. Mazzocchi, L. K. Malendowicz, L. Gottardo, F. Aragona and G. G. Nussdorfer, Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade, J Clin Endocrinol Metab. 86, 778-82. (2001).
42. T. Nanmoku, K. Isobe, T. Sakurai, A. Yamanaka, K. Takekoshi, Y. Kawakami, K. Goto and T. Nakai, Effects of orexin on cultured porcine adrenal medullary and cortex cells, Regul Pept. 104, 125-130 (2002).
43. R. Xu, Q. Wang, M. Yan, M. Hernandez, C. Gong, W. C. Boon, Y. Murata, Y. Ueta and C. Chen, Orexin-A augments voltage-gated Ca2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes, Endocrinology. 143, 4609-19 (2002).
44. K. P. Larsson, K. E. Akerman, J. Magga, S. Uotila, J. P. Kukkonen, J. Nasman and K. H. Herzig, The STC-1 cells express functional orexin-A receptors coupled to CCK release, Biochem Biophys Res Commun. 309, 209-16 (2003).
45. D. Smart, J. C. Jerman, S. J. Brough, W. A. Neville, F. Jewitt and R. A. Porter, The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors, Br J Pharmacol. 129, 1289-91 (2000).
46. T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, R. M. Chemelli, H. Tanaka, S. C. Williams, J. A. Richardson, G. P. Kozlowski, S. Wilson, J. R. Arch, R. E. Buckingham, A. C. Haynes, S. A. Carr, R. S. Annan, D. E. McNulty, W. S. Liu, J. A. Terrett, N. A. Elshourbagy, D. J. Bergsma and M. Yanagisawa, Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior, Cell. 92, 573-85 (1998).
47. P. E. Lund, R. Shariatmadari, A. Uustare, M. Detheux, M. Parmentier, J. P. Kukkonen and K. E. Akerman, The Orexin OX1 Receptor Activates a Novel Ca2+ Influx Pathway Necessary for Coupling to Phospholipase C, J Biol Chem. 275, 30806-30812 (2000).
48. T. Holmqvist, K. E. Akerman and J. P. Kukkonen, Orexin signaling in recombinant neuron-like cells, FEBS Lett. 526, 11-4 (2002).
49. Y. Zhu, Y. Miwa, A. Yamanaka, T. Yada, M. Shibahara, Y. Abe, T. Sakurai and K. Goto, Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins, J Pharmacol Sci. 92, 259-66 (2003).
50. J. P. Kukkonen and K. E. Akerman, Orexin receptors couple to Ca2+ channels different from store-operated Ca2+ channels, Neuroreport. 12, 2017-20 (2001).
51. S. Ammoun, T. Holmqvist, R. Shariatmadari, H. B. Oonk, M. Detheux, M. Parmentier, K. E. Akerman and J. P. Kukkonen, Distinct recognition of OX1 and OX2 receptors by orexin peptides, J Pharmacol Exp Ther. 305, 507-14 (2003).
52. Q. V. Hoang, P. Zhao, S. Nakajima and Y. Nakajima, Orexin (Hypocretin) Effects on Constitutively Active Inward Rectifier K+ Channels in Cultured Nucleus Basalis Neurons, J Neurophysiol. (2004).
53. S. Muroya, H. Funahashi, A. Yamanaka, D. Kohno, K. Uramura, T. Nambu, M. Shibahara, M. Kuramochi, M. Takigawa, M. Yanagisawa, T. Sakurai, S. Shioda and T. Yada, Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus, Eur J Neurosci. 19, 1524-34 (2004).
54. J. S. Gutkind, Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors, Sci STKE. 2000, RE1 (2000).
55. T. Gudermann, R. Grosse and G. Schultz, Contribution of receptor/G protein signaling to cell growth and transformation, Naunyn Schmiedebergs Arch Pharmacol. 361, 345-62 (2000).
56. S. Hilairet, M. Bouaboula, D. Carriere, G. Le Fur and P. Casellas, Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716, J Biol Chem. 278, 23731-7 (2003).
57. O. Selbach, N. Doreulee, C. Bohla, K. S. Eriksson, O. A. Sergeeva, W. Poelchen, R. E. Brown and H. L. Haas, Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling, Neuroscience. 127, 519-28 (2004).